Data from SAGE are available through NCBI dbGaP under accession number phs000921.v3.p1. All simulation data files and results are available online through Dryad at <https://doi.org/10.7272/Q6RN362Z>. All source code for analyses in this manuscript is available on Github at <https://github.com/asthmacollaboratory/sage-geuvadis-predixcan>.

Introduction {#sec001}
============

In the last decade, large-scale genome-wide genotyping projects have enabled a revolution in our understanding of complex traits \[[@pgen.1008927.ref001]--[@pgen.1008927.ref004]\]. This explosion of genome sequencing data has spurred the development of new methods that integrate large genotype sets with additional molecular measurements such as gene expression. A recently popular integrative approach to genetic association analyses, known as a transcriptome-wide association study (TWAS) \[[@pgen.1008927.ref005],[@pgen.1008927.ref006]\], leverages reference datasets such as the Genotype-Tissue Expression (GTEx) repository \[[@pgen.1008927.ref007]\] or the Depression and Genes Network (DGN) \[[@pgen.1008927.ref008]\] to link associated genetic variants with a molecular trait like gene expression. The general TWAS framework requires previously estimated *cis*-eQTLs for all genes in a dataset with both genotype and gene expression measurements. The resulting eQTL effect sizes build a predictive model that can impute gene expression in an independently genotyped population. A TWAS is similar in spirit to the widely-known genome-wide association study (GWAS) but suffers less of a multiple testing burden and can potentially detect more associations as a result \[[@pgen.1008927.ref005],[@pgen.1008927.ref006]\].

Unlike a normal GWAS, where phenotypes are regressed onto genotypes, in TWAS the phenotype is regressed onto the imputed gene expression values, thus constituting a new gene-based association test. TWAS can also link phenotypes to variation in gene expression and provide researchers with additional biological and functional insights over those afforded by GWAS alone. While these models are imperfect predictors, predicted gene expression allows researchers to test phenotype associations to expression levels in existing GWAS datasets without measuring gene expression directly. In particular, these methods enable analysis of predicted gene expression in very large cohorts (\~10^4^--10^6^ individuals) rather than typical gene expression studies that measure expression directly (\~10^2^--10^3^ individuals). Several methods have been recently developed to perform TWAS in existing genotyped datasets. PrediXcan \[[@pgen.1008927.ref006]\] uses eQTLs precomputed from paired genotype-expression data, such as those in GTEx, in conjunction with a new genotype set to predict gene expression. These gene expression prediction models are freely available online (PredictDB), creating resources for external researchers. Related TWAS approaches, such as FUSION\[[@pgen.1008927.ref005]\], MetaXcan \[[@pgen.1008927.ref009]\], or SMR \[[@pgen.1008927.ref010]\], leverage eQTL information with GWAS summary statistics instead, thus circumventing the need for raw individual-level genotype data.

As evidenced by application to numerous disease domains, the TWAS framework is capable of uncovering new genic associations \[[@pgen.1008927.ref011]--[@pgen.1008927.ref017]\]. However, the power of TWAS is inherently limited by the data used for eQTL discovery. For example, since gene expression varies by tissue type, researchers must ensure that the prediction weights are estimated using RNA from a tissue related to their phenotype, whether that be the direct tissue of interest or one with sufficiently correlated gene expression \[[@pgen.1008927.ref018]\]. Furthermore, the ability of predictive models to impute gene expression from genotypes is limited by the heritability in the *cis* region around the gene \[[@pgen.1008927.ref006]\]. Consequently, genes with little or no measurable genetically regulated effect on their expression in the discovery data are poor candidates for TWAS.

A subtler but more troubling issue arises from the lack of genetic diversity present in the datasets used for predictive model training: most paired genotype-expression datasets consist almost entirely of data from European-descent individuals \[[@pgen.1008927.ref008],[@pgen.1008927.ref018]\]. The European overrepresentation in genetic studies is well documented \[[@pgen.1008927.ref019]--[@pgen.1008927.ref021]\] and has severe negative consequences for equity as well as for gene discovery \[[@pgen.1008927.ref022]\], fine mapping \[[@pgen.1008927.ref023]--[@pgen.1008927.ref025]\], and applications in personalized medicine \[[@pgen.1008927.ref026]--[@pgen.1008927.ref034]\]. Genetic architecture, linkage disequilibrium, and genotype frequencies can vary across populations, which presents a potential problem for the application of predictive models with genotype predictors across multiple populations.

The training data for most models in the models derived from PrediXcan weights in PredictDB ([predictdb.org](http://predictdb.org)) are highly biased toward European ancestry: GTEx version v6p subjects are over 85% European, while the GTEx v7 and DGN subjects are entirely of European descent. The lack of suitable genotype-expression datasets in non-European individuals leads to scenarios in which PredictDB models trained in Europeans are used to predict into non-European or admixed populations. As shown previously in the context of polygenic risk scores \[[@pgen.1008927.ref035]\], multi-SNP prediction models trained in one population can suffer from unpredictable bias and poor prediction accuracy that impair their cross-population generalizability. Recent analyses of genotype-expression data from the Multi-Ethnic Study of Atherosclerosis (MESA) \[[@pgen.1008927.ref036]--[@pgen.1008927.ref038]\], which includes non-European individuals, explore cross-population transcriptome prediction and conclude that predictive accuracy is highest when training and testing populations match in ancestry. These results are consistent with our experience analyzing admixed populations, but offer little insight into the mechanisms underlying the cross-population generalizability of transcriptome prediction models, particularly when eQTL architecture is known.

Here we investigate the cross-population generalizability of gene expression models using paired genotype and gene expression data and using simulations derived from real genotypic data and realistic models of gene expression. We analyze prediction quality from currently available PrediXcan prediction weights using a pilot subset of paired genotype and whole blood transcriptome data from the Study of African Americans, Asthma, Genes, and Environment (SAGE) \[[@pgen.1008927.ref039]--[@pgen.1008927.ref042]\]. SAGE is a pediatric cohort study of childhood-onset asthma and pulmonary phenotypes in African American subjects of 8 to 21 years of age. To tease apart cross-population prediction quality, we turn to GEUVADIS and the 1000 Genomes Project datasets, which includes multiple populations each with more samples than our SAGE cohort \[[@pgen.1008927.ref004],[@pgen.1008927.ref043],[@pgen.1008927.ref044]\]. The GEUVADIS dataset has been used extensively to validate PrediXcan models \[[@pgen.1008927.ref006],[@pgen.1008927.ref038]\]. However, recent analyses suggest that GTEx and DGN PrediXcan models behave differently on the constituent populations in GEUVADIS \[[@pgen.1008927.ref045],[@pgen.1008927.ref046]\]. GEUVADIS provides us an opportunity to investigate predictive models with an experimentally homogeneous dataset: the GEUVADIS RNA-Seq data were produced in the same environment under the same protocol, from lymphoblastoid cell lines (LCLs) that, despite some variation in when cells were collected \[[@pgen.1008927.ref047]\], are derived from similar sampling efforts and treatments, thereby providing a high degree of technical harmonization. We train, test, and validate predictive models wholly within GEUVADIS with a nested cross-validation scheme. Finally, to understand the consequences of eQTL architecture on TWAS, we use existing 1000 Genomes data to simulate large samples of two ancestral populations and an admixed population and then apply the same "train-test-validate" scheme with various simulated eQTL models to study cross-population prediction efficacy when a gold standard is known.

Results {#sec002}
=======

Concordance of measured gene expression and PrediXcan predictions is lower than expected {#sec003}
----------------------------------------------------------------------------------------

We compared transcriptome prediction accuracy in SAGE whole blood RNA using three PredictDB prediction weight sets for whole blood RNA: GTEx v6p, GTEx v7, and DGN. We also evaluated expression prediction with four of the MESA monocyte weight sets: MESA_ALL (populations combined), MESA_AFA (African Americans), MESA_AFHI (combined African Americans and Hispanic Americans), and MESA_CAU (Caucasians). For each gene where both measured RNA-Seq gene expression and predictions are available in SAGE, we compute both the coefficient of determination (R^2^) and Spearman correlation to analyze the direction of prediction. As we are primarily interested in describing the relationship between predicted outcome and real outcome, we prefer Spearman's *ρ* to describe correlations, while for determining prediction accuracy, we use the standard regression R^2^, corresponding to the squared Pearson correlation, to facilitate comparisons to prior work. We then benchmark these against the out-of-sample R^2^ and correlations from GTEx v7 and MESA as found in PredictDB. Prediction results in SAGE were available for 11,545 genes with a predictive model from at least one weight set. Not all sets derived models at the same genes: since the estimation of these prediction models requires both high quality expression data and inferred eQTLs, each weight set from PredictDB may have a different number of gene models. Therefore, intersecting seven different weight sets reduces the overall number of models available for comparison. After applying the recommended filters, the prediction results across all seven weight sets overlapped at 273 genes, of which 39 genes had predictions with positive correlation to measurements. These subsets contained genes that were expressed somewhat higher than average ([S1 Fig](#pgen.1008927.s013){ref-type="supplementary-material"}). This small number of genes in common is largely driven by MESA_AFA, the repository with the smallest number of predictive models. However, MESA_AFA contains the models that should best reflect the genetic ancestry of African Americans in SAGE ([S1 Table](#pgen.1008927.s001){ref-type="supplementary-material"}). We note that MESA_AFA also has the smallest training sample size among our weight sets (N = 233) \[[@pgen.1008927.ref038]\], so the small number of predicted genes from MESA_AFA probably results from the small training sample size and not from any feature of the underlying MESA_AFA training data.

Here, we highlight the union of genes across model sets for investigation. The concordance between predicted and measured gene expression over the union of 11,545 from all seven weight sets, with corresponding training metrics from PredictDB as benchmarks, shows worse performance than expected for R^2^ ([Fig 1](#pgen.1008927.g001){ref-type="fig"}) and correlations ([Fig 2](#pgen.1008927.g002){ref-type="fig"}). The highest mean R^2^ of 0.0298 was observed in MESA_AFA, while the lowest was observed in MESA_ALL (R^2^ = 0.0250), suggesting little appreciable difference in prediction quality between prediction weight sets. R^2^ for SAGE cluster heavily around 0 ([S2 Fig](#pgen.1008927.s014){ref-type="supplementary-material"}), while R^2^ for the prediction weight repositories show a wider distribution of R^2^ ([S3 Fig](#pgen.1008927.s015){ref-type="supplementary-material"}). We note the intersection of all prediction models is limited, but reflects a similar pattern: results for the 273 common genes ([S4](#pgen.1008927.s016){ref-type="supplementary-material"}--[S6](#pgen.1008927.s018){ref-type="supplementary-material"} Figs) and the 39 genes with positive correlations ([S7](#pgen.1008927.s019){ref-type="supplementary-material"} and [S8](#pgen.1008927.s020){ref-type="supplementary-material"} Figs) showed little difference from the R^2^ shown in [Fig 1](#pgen.1008927.g001){ref-type="fig"}. Because SAGE is an independent validation set for the training populations, we would expect to observe some deterioration in prediction R^2^ due to out-of-sample estimation. However, [Fig 1](#pgen.1008927.g001){ref-type="fig"} shows a marked difference in model performance.

![A comparison of R^2^ between prediction and measurement in SAGE, with PredictDB test metrics as benchmarks, for 11,545 genes total.\
The prediction weights used here are, from left to right: GTEx v6p, GTEx v7, DGN, MESA African Americans, MESA African Americans and Hispanics, MESA Caucasians, and all MESA subjects. Test R^2^ from model training in GTEx 7 and MESA ("test_R2_avg" in PredictDB) appear on the right and provide a performance baseline. The number of genes per weight set varies; see [S1 Table](#pgen.1008927.s001){ref-type="supplementary-material"}.](pgen.1008927.g001){#pgen.1008927.g001}

![Spearman correlations of measured gene expression versus predicted expression from PrediXcan.\
The order of the weight sets matches [Fig 1](#pgen.1008927.g001){ref-type="fig"}. Test correlations for GTEx v7 and MESA correspond to "rho_avg" from PredictDB.](pgen.1008927.g002){#pgen.1008927.g002}

More noteworthy is the substantial proportion of predictions in SAGE with negative correlations to the real data. All seven weight sets produced gene expression predictions with negative correlations, but average performance across genes varied. The least negative mean correlation across prediction weight sets was observed in GTEx v6p (-0.0044), while the most negative mean correlation (-0.0204) was observed with MESA_AFA (MESA African Americans, [S1 Table](#pgen.1008927.s001){ref-type="supplementary-material"}). The observation that correlations to SAGE measurements are sometimes negative on average suggests that some large R^2^ values seen in [Fig 1](#pgen.1008927.g001){ref-type="fig"} may result from gene models with incorrect direction of prediction, thereby limiting interpretability of results. While there are some fluctuations in prediction accuracy, the fact that correlations vary from -0.0204 to -0.0044 indicates that no prediction weight set produces practically meaningfully better correlations to data than the others. In contrast, the published models for these genes show positive correlations to their training data, ranging from 0.308 in GTEx_v7 to 0.379 in MESA_AFA, indicating no obvious incapacity for accurate prediction, even with out-of-sample data. However, available predictions into SAGE from otherwise valid prediction models are uniformly limited in power to capture true genotype-expression relationships.

To analyze genes with high prediction R^2^ in the original experiment, we focus on genes in GTEx v7 with cross-validated R^2^ \> 0.2 in the reference population. Our choice of R^2^ is informed by observed R^2^ between predictions and measurements in DGN (see Fig 3 of \[[@pgen.1008927.ref006]\]) and focuses our analysis on genes predicted better than average. [Fig 3](#pgen.1008927.g003){ref-type="fig"} compares PredictDB testing R^2^ against the empirical R^2^ from regressing predictions onto observations in SAGE. In this case, even the better-imputed gene models derived from PredictDB have limited ability to capture gene expression accurately in SAGE (mean R^2^ 0.031, IQR \[0.0027, 0.037\]). We see a similar trend with MESA models ([S9](#pgen.1008927.s021){ref-type="supplementary-material"}--[S12](#pgen.1008927.s024){ref-type="supplementary-material"} Figs), in which R^2^ in SAGE is consistently much lower (mean R^2^ 0.026--0.030) than test R^2^ from each prediction weight set (test R^2^ 0.373--0.392).

![A comparison of R^2^ from SAGE and GTEx v7 training diagnostics.\
The SAGE R^2^ are computed from regressing PrediXcan predictions onto gene expression measurements. The GTEx v7 R^2^ are taken from PredictDB ("test_R2_avg"). The red dotted line marks where R^2^ between the two groups match, while the blue line denotes the best linear fit.](pgen.1008927.g003){#pgen.1008927.g003}

Since SAGE data were ascertained on the basis of rs28450894 and by extension gene *NFKB1* \[[@pgen.1008927.ref039]\], we checked if results were biased by ascertainment. Among the 273 genes in common to all weight sets, only one gene model, *SLC39A8*, lay within 1 megabase in either direction of rs28450894 on chromosome 4. Only two of the SNP predictors for *SLC39A8* showed more than moderate linkage disequilibrium (R^2^ \> 0.2) with rs28450894: SNP rs72696152 (MESA_ALL, R^2^ = 0.675) and rs4648011 (DGN, R^2^ = 0.262) ([S3 Table](#pgen.1008927.s003){ref-type="supplementary-material"}). However, the resulting prediction quality were close to 0 like the remaining 272 genes, as the linear model R^2^ for SLC39A8 ranged from 0.0007 (GTEx v7) to 0.0102 (GTEx v6p), indicating no obvious bias away from 0 ([S4 Table](#pgen.1008927.s004){ref-type="supplementary-material"}).

Cross-population prediction quality declines with increasing genetic distance {#sec004}
-----------------------------------------------------------------------------

Real-world comparisons of RNA-Seq datasets can be subject to numerous sources of heterogeneity besides differential ancestry. Possible confounders include technical differences in sequencing protocols, differences in the age of participants \[[@pgen.1008927.ref048]\] or cell lines \[[@pgen.1008927.ref047]\], and the postmortem interval to tissue collection (for GTEx) \[[@pgen.1008927.ref049]--[@pgen.1008927.ref051]\]. The small sample size of our SAGE cohort (*n* = 39) limits our ability to account for these possible confounders. To investigate cross-population generalizability in an experimentally homogeneous context, we turn to GEUVADIS \[[@pgen.1008927.ref043]\]. The GEUVADIS data include two continental population groups from the 1000 Genomes Project: the Europeans (EUR373), composed of 373 unrelated individuals from four subpopulations (Utahns (CEU), Finns (FIN), British (GBR), Toscani (TSI)), and the Africans (AFR) composed of 89 unrelated Yoruba (YRI) individuals. In light of the known bottleneck in Finnish population history \[[@pgen.1008927.ref052]\], we analyze EUR373 both as one population and as two independent subgroups: the 95 Finnish individuals (FIN) and the 278 non-Finnish Europeans (EUR278). We used expression data, generated and harmonized together by the GEUVADIS Consortium, with matched whole-genome genotype data in the resulting four populations (EUR373, EUR278, FIN, and AFR) to train predictive models for gene expression in a nested cross-validation scheme \[[@pgen.1008927.ref006]\] and perform cross-population tests of prediction accuracy.

[Table 1](#pgen.1008927.t001){ref-type="table"} shows R^2^ from three training sets (EUR373, EUR278 and AFR) into the four testing populations (EUR373, EUR278, FIN, and AFR) for genes with positive correlation between prediction and measurement. While the number of genes with applicable models including genetic data varies in each train-test scenario (see [S5 Table](#pgen.1008927.s005){ref-type="supplementary-material"}), we note that not all predictive models are trained on equal sample sizes, so the resulting R^2^ only provide a general idea of how well one population imputes into another; see [S13 Fig](#pgen.1008927.s025){ref-type="supplementary-material"} for a distributional summary. Analyses within a population use out-of-sample prediction R^2^ to avoid overfitting across train-test scenarios. Predicting from a population into itself yields R^2^ ranging from 0.079--0.098 ([Table 1](#pgen.1008927.t001){ref-type="table"}) consistent with the smaller sample sizes in GEUVADIS versus GTEx and DGN. In contrast, predicting across populations yields more variable predictions, with R^2^ ranging from 0.029--0.087. At the lower range of R^2^ (0.029--0.039) are predictions from AFR into European testing groups (EUR373, EUR278, and FIN). Alternatively, when predicting from European training groups into AFR, the R^2^ are noticeably higher (0.051--0.054). Prediction from EUR278 into FIN (R^2^ = 0.087) is better than prediction from EUR278 into AFR (R^2^ = 0.051), suggesting that prediction R^2^ may deteriorate with increased genetic distance. A comparison of the 564 genes in common across all train-test scenarios ([Table 2](#pgen.1008927.t002){ref-type="table"}) yields a subset of genes with potentially more consistent gene expression levels (see [S14 Fig](#pgen.1008927.s026){ref-type="supplementary-material"} for distributional summaries). In this case involving better-predicted genes, we see that prediction quality between the European groups improves noticeably (*p*-value \~ 0, Dunn test). Among European training sets, the lowest R^2^ is 0.183 for EUR278 predicting into EUR278. R^2^ increases to 0.201 (EUR373 to EUR373) and attains its maximum at 0.216 (EUR278 to FIN), possibly a consequence of diminished haplotypic diversity from Finnish population bottlenecking as mentioned previously. In contrast, R^2^ between Europeans and Africans ranges from 0.095 (AFR to EUR373) to 0.147 (EUR373 to AFR), a significant improvement (*p*-value \< 7.07 x 10^−22^, Dunn test) that nonetheless highlights a continental gap in prediction performance. AFR predicts better into FIN (R^2^ = 0.111) than the other European populations (R^2^ = 0.095--0.096), similar to what we observe with predictions from EUR373 into FIN. But AFR predicts better into itself (R^2^ = 0.130) than to other populations; similarly, European predictions into AFR are noticeably lower (R^2^ = 0.141--0.147) than into other European populations (R^2^ = 0.183--0.216). In general, populations seem to predict better into themselves, and less well into other populations.

10.1371/journal.pgen.1008927.t001

###### Prediction R^2^ between populations in GEUVADIS for genes with positive correlation between predictions and measurements.

The number of genes analyzed in each scenario varied in each case; see [S5 Table](#pgen.1008927.s005){ref-type="supplementary-material"}. Scenarios where the training sample is contained in the testing sample cannot be accurately tested and are marked with "n/a". EUR373 includes all 373 Europeans, EUR278 includes only the 278 non-Finnish Europeans, FIN includes only the 95 Finnish individuals, and AFR includes only the 89 Yoruba.

![](pgen.1008927.t001){#pgen.1008927.t001g}

  R^2^           Train Pop                    
  -------------- ------------ ------- ------- -------
  **Test Pop**   **EUR373**   0.098   n/a     0.029
  **EUR278**     n/a          0.096   0.030   
  **FIN**        n/a          0.087   0.039   
  **AFR**        0.054        0.051   0.079   

10.1371/journal.pgen.1008927.t002

###### Prediction R^2^ between populations in GEUVADIS for 564 gene models that show positive correlation between prediction and measurement in all 9 train-test scenarios that were analyzed.

Scenarios that were not tested are marked with "n/a". As before, EUR373 includes all 373 Europeans, EUR278 includes only the 278 non-Finnish Europeans, FIN includes only the 95 Finnish individuals, and AFR includes only the 89 Yoruba.

![](pgen.1008927.t002){#pgen.1008927.t002g}

  ---------------------------------------------------
  R^2^\          Train Pop                    
  (564 genes)                                 
  -------------- ------------ ------- ------- -------
  **Test Pop**   **EUR373**   0.201   n/a     0.096

  **EUR278**     n/a          0.183   0.095   

  **FIN**        n/a          0.216   0.111   

  **AFR**        0.147        0.141   0.130   
  ---------------------------------------------------

Combining all European subpopulations obscures population structure and can complicate analysis of cross-population prediction performance. To that end, we divide the GEUVADIS data into its five constituent populations and randomly subsample each of them to the smallest population size (*n* = 89). We then estimate models from each subpopulation and predict into all five subpopulations. [Table 3](#pgen.1008927.t003){ref-type="table"} shows average prediction R^2^ from each population into itself and others (see [S15 Fig](#pgen.1008927.s027){ref-type="supplementary-material"} for distributional summaries). The populations consistently predict well into themselves, with prediction R^2^ ranging from 0.104--0.136. We observe that prediction quality using models trained in CEU shows a miniscule decline relative to other EUR subpopulations. This observation is potentially due to the older age of CEU LCLs \[[@pgen.1008927.ref045],[@pgen.1008927.ref053],[@pgen.1008927.ref054]\], but did not appreciably change our results. In contrast, a more notable difference exists between the EUR subpopulations and YRI. The cross-population R^2^ between CEU, TSI, GBR, and FIN ranges from 0.103 to 0.137, while cross-population R^2^ from these populations into YRI ranges from 0.062 to 0.084. Prediction between YRI and the EUR populations taken together is consistently lower than within the EUR populations ([S17 Fig](#pgen.1008927.s029){ref-type="supplementary-material"}) and statistically significant (*p*-value \< 1.36 x 10^−4^, Dunn test; see [S8 Table](#pgen.1008927.s008){ref-type="supplementary-material"}). The cross-population differences remain for the 142 genes with positive correlation in all train-test scenarios ([Table 4](#pgen.1008927.t004){ref-type="table"}, [S16 Fig](#pgen.1008927.s028){ref-type="supplementary-material"}), where R^2^ for prediction into YRI ranges from 0.166 to 0.244, while R^2^ within EUR populations ranges from 0.239 to 0.331. These results clearly suggest problems for prediction models that predict gene expression across populations, in similar regimes to those tested with linear predictive models and datasets of size consistent with current references. In addition, since AFR is genetically more distant from the EUR subpopulations than they are to each other, we interpret these results to imply that structure in populations can potentially exacerbate cross-population prediction quality ([S18 Fig](#pgen.1008927.s030){ref-type="supplementary-material"}).

10.1371/journal.pgen.1008927.t003

###### Cross-population prediction performance across all five constituent GEUVADIS populations over genes with positive correlation between predictions and measurements.

All populations were subsampled to N = 89 individuals. The number of genes represented varies by training sample (CEU: N = 1029, FIN: N = 1320, GBR: 1436, TSI: 1250, YRI: 914).

![](pgen.1008927.t003){#pgen.1008927.t003g}

  R2 Mean (Std Err)   Training population                                         
  ------------------- --------------------- --------- --------- --------- ------- -------
  **Testing Pop**     **CEU**               0.115     0.106     0.107     0.103   0.069
  (0.139)             (0.139)               (0.134)   (0.133)   (0.116)           
  **TSI**             0.124                 0.121     0.124     0.118     0.083   
  (0.158)             (0.151)               (0.149)   (0.145)   (0.13)            
  **GBR**             0.132                 0.137     0.136     0.133     0.087   
  (0.16)              (0.155)               (0.156)   (0.155)   (0.132)           
  **FIN**             0.128                 0.130     0.130     0.130     0.084   
  (0.158)             (0.155)               (0.153)   (0.152)   (0.134)           
  **YRI**             0.065                 0.069     0.063     0.062     0.104   
  (0.108)             (0.112)               (0.1)     (0.102)   (0.138)           

10.1371/journal.pgen.1008927.t004

###### Cross-population prediction performance across all five subsampled GEUVADIS populations over the 142 genes with positive correlation between prediction and measurement in all 25 train-test scenarios.

As in [Table 3](#pgen.1008927.t003){ref-type="table"}, all populations were subsampled to n = 89 subjects.

![](pgen.1008927.t004){#pgen.1008927.t004g}

  -----------------------------------------------------------------------------------------------------------
  R2 Mean (Std Err)\                      Training population                                         
  (142 genes, all positive correlation)                                                               
  --------------------------------------- --------------------- --------- --------- --------- ------- -------
  **Testing Pop**                         **CEU**               0.239     0.269     0.291     0.297   0.201

  (0.18)                                  (0.177)               (0.166)   (0.168)   (0.164)           

  **TSI**                                 0.307                 0.294     0.331     0.322     0.227   

  (0.188)                                 (0.21)                (0.182)   (0.185)   (0.185)           

  **GBR**                                 0.320                 0.326     0.318     0.350     0.235   

  (0.175)                                 (0.181)               (0.191)   (0.178)   (0.183)           

  **FIN**                                 0.318                 0.320     0.343     0.323     0.244   

  (0.191)                                 (0.198)               (0.182)   (0.201)   (0.192)           

  **YRI**                                 0.166                 0.205     0.195     0.189     0.213   

  (0.164)                                 (0.163)               (0.157)   (0.156)   (0.177)           
  -----------------------------------------------------------------------------------------------------------

Admixture influences cross-population gene expression prediction quality under known eQTL architecture {#sec005}
------------------------------------------------------------------------------------------------------

The unresolved question is the extent to which these results hold with oracle knowledge of eQTL architecture, something impossible to investigate in real data when the causal links between eQTLs and gene expression can only be estimated. To investigate genomic architectures giving rise to gene expression, and in particular to investigate behavior in admixed populations, we forward-simulated haplotypes from HapMap3 \[[@pgen.1008927.ref055]\] CEU and YRI using HAPGEN2 \[[@pgen.1008927.ref056]\] and then sample haplotypes in proportions consistent with realistic admixture proportions (80% YRI, 20% CEU) \[[@pgen.1008927.ref057]\] to construct a simulated African-American (AA) admixed population. We simulated *n* = 1000 samples for each population, a much larger sample than what is available in GEUVADIS and comparable to the training sample size of DGN or MESA_ALL PrediXcan models. We simulated eQTL architectures under an additive model of size *k* causal alleles (*k* = 1, 10, 20, and 40) in the ancestral populations (CEU and YRI) and an expression phenotype with *cis*-heritability *h*^2^ = 0.15 (recapitulating the average *h*^2^ in DGN whole blood RNA-Seq data \[[@pgen.1008927.ref006]\]) using the genomic background of genic regions on chromosome 22, thus testing various model sizes and LD patterns. To tease apart the effect of shared eQTL architecture, we allow the two ancestral populations CEU and YRI to share eQTLs with fixed effects in various proportions (0%, 10%, 20%, ..., 100%) to test a range of eQTL architectures. The admixed population AA always inherited all eQTLs from the two ancestral populations, which yielded different numbers of eQTLs per gene depending on how many eQTLs were shared by CEU and YRI. For example, for eQTL model size *k* = 10, when CEU and YRI shared all 10 eQTLs, then all three populations had the exact same 10 eQTLs. When CEU and YRI shared half of their eQTLs with each other, then each one had 5 population-specific eQTLs, and AA inherited 15 total eQTLs (5 unique to CEU, 5 unique to YRI, and 5 shared). If CEU and YRI shared no eQTLs, then all eQTLs were population-specific, and AA inherited 20 eQTLs (10 from CEU and 10 from YRI; see [S19 Fig](#pgen.1008927.s031){ref-type="supplementary-material"} for an illustration). With these simulations providing known architectures for comparison, we then apply the train-test-validate scheme as before.

[Fig 4](#pgen.1008927.g004){ref-type="fig"} shows the cross-population Spearman correlations between predicted and simulated phenotypes in our simulated AA, CEU, and YRI, partitioned by proportion of shared eQTLs, for *k* = 10 causal eQTLs in the ancestral populations (CEU and YRI). Scenarios with k = 20 and k = 40 causal eQTLs show similar trends ([S20 Fig](#pgen.1008927.s032){ref-type="supplementary-material"} and [S21 Fig](#pgen.1008927.s033){ref-type="supplementary-material"}). Prediction within a population produced similar correlations in all cases, ranging from 0.310 to 0.338 ([S6 Table](#pgen.1008927.s006){ref-type="supplementary-material"}). The case of models with 100% shared eQTL architecture--where eQTL positions and effects are exactly the same between the ancestral populations--yields predictions with no loss in cross-population generalizability, with correlations ranging from 0.299 to 0.336 even when predicting across populations ([S7 Table](#pgen.1008927.s007){ref-type="supplementary-material"}). This case suggests that eQTLs that are causal in all populations can impute gene expression reliably regardless of the population in which they were ascertained, provided that the eQTLs can be correctly mapped and genotyped in all populations, that the eQTL effects are identical across populations, and that a linear model of eQTLs is assumed. For cases where eQTL architecture is not fully shared across populations, we see that prediction from each population into the other improves as the proportion of shared eQTLs increases ([Fig 4](#pgen.1008927.g004){ref-type="fig"}). The cross-population correlation between predicted gene expression versus measurement is highest from YRI to AA (0.238 to 0.338), intermediate from CEU to AA (0.218 to 0.310), and lowest between CEU and YRI (0.0020 to 0.326). Prediction quality from AA to CEU and YRI interpolates that of YRI to AA and CEU to AA, with correlations ranging from 0.223 to 0.338. Prediction quality from AA to CEU or YRI shows a slight upward trend as more eQTLs are shared, an artifact of eQTL inheritance in our simulations; as described previously, AA eQTL models are largest (20 eQTLs) when CEU and YRI share no eQTLs and smallest (10 eQTLs) when CEU and YRI share all eQTLs. Consequently, when predicting between two populations, the choice of which population is used to train predictive models can produce differences in prediction quality. Prediction quality between AA to CEU and AA to YRI is not significantly different (p-value \~ 1, Dunn test). All other train/test scenarios are significantly different from each other ([S9 Table](#pgen.1008927.s009){ref-type="supplementary-material"}). The results for k = 10, 20, and 40 eQTLs show a consistent trend of prediction quality driven primarily by differences in eQTL architecture, with additional minor influence from ancestral similarity between populations (k = 10, [Fig 4](#pgen.1008927.g004){ref-type="fig"}, similar plots in [S20 Fig](#pgen.1008927.s032){ref-type="supplementary-material"} and [S21 Fig](#pgen.1008927.s033){ref-type="supplementary-material"}). Although less realistic for most genes \[[@pgen.1008927.ref005],[@pgen.1008927.ref006],[@pgen.1008927.ref018]\], we also analyzed models with a single causal eQTL. Trends for single-eQTL models are more difficult to analyze due the limitations of binary inference as to whether the causal SNP is identified or not. Nevertheless, when the causal eQTL is identified and shared across populations, prediction quality is high in all cases. If the causal eQTL differs across populations, then cross-population prediction between AA and YRI or CEU is noticeably better than prediction between CEU and YRI ([S22 Fig](#pgen.1008927.s034){ref-type="supplementary-material"}), in line with results for other values of *k* that suggest that eQTL sharing is the primary driver of gene expression prediction quality.

![Correlations between predictions and simulated gene expression measurements from simulated populations across various proportions of shared eQTL architecture with 10 causal cis-eQTLs.\
Here YRI is simulated from the 1000 Genomes Yoruba, CEU is simulated from the Utahns, and AA is constructed from YRI and CEU. The black line represents the upper bound of correlation 0.387 dictated by our choice h^2^ = 0.15 for the genetic heritability of expression. Each trend line represents an interpolation of correlation versus shared eQTL proportion. Gray areas denote 95% confidence regions of LOESS-smoothed mean correlations conditional on the proportion of shared eQTLs.](pgen.1008927.g004){#pgen.1008927.g004}

Power to detect associations declines with decreasing shared ancestry {#sec006}
---------------------------------------------------------------------

Simulation of gene expression demonstrates that gene expression prediction quality is modulated by both shared eQTL architecture and shared genetic ancestry. These results suggest possible effects of cross-population generalizability on the power to detect associations between a phenotype and gene expression measures in a TWAS. For each of our three populations (AA, CEU, and YRI), we used the simulated gene expression measures to simulate a continuous phenotype whose variation depends on expression of a single causal gene. For simplicity, the phenotypes shared the same causal gene, the same effect size, and the same environmental noise model. We tested various effect sizes from 1 x 10^−5^ to 1 and drew the environmental noise from a zero-mean normal distribution with variance 0.01. The effect sizes produced a continuous spectrum of genetic heritability values *h*^2^ spanning the full range of heritability for gene expression. We then regressed the phenotype onto predicted gene expression measures, resulting in nine association tests, one for each train-test scenario. For simplicity, we focused on the prediction scenario with *k* = 10 causal eQTLs per gene. To see how shared eQTL architecture affects power, we used predicted expression measures with 0%, 50%, and 100% shared eQTLs per gene.

[Fig 5](#pgen.1008927.g005){ref-type="fig"} shows power curves for the association tests for the nine prediction scenarios for all three tested eQTL architectures. Unsurprisingly, power improves as populations share more causal eQTLs and as more phenotypic heritability is driven by gene expression. For example, with 100% shared eQTLs and phenotypic heritability 0.205, cross-population power ranges between 0.69--0.86. In contrast, average power under a model of 0% shared eQTLs between ancestral populations (CEU to YRI, YRI to CEU), varies from a scant 0.02 to 0.14 as phenotype heritability increases from 0 to 1, indicating some ability to predict gene expression at genetically controlled genes even without shared eQTLs. AA shows better cross-population power, ranging from to 0.38 (AA to YRI, AA to CEU) to 0.82 (CEU to AA) and 0.88 (YRI to AA), an expected outcome since AA inherits all eQTLs from the ancestral populations. Power also improves with shorter genetic distance between populations. [Fig 6](#pgen.1008927.g006){ref-type="fig"}, which is a cross-section of [Fig 5](#pgen.1008927.g005){ref-type="fig"}, shows power for each train-test scenario across various shared eQTL architectures for β = 0.05, corresponding to a phenotype heritability of *h*^*2*^ = 0.205, indicating moderate genetic control. TWAS in this case using gene expression imputed from matched populations has higher power across all eQTL architectures, from 0.88--1.00, compared to cross-population TWAS, where power varies substantially. For an architecture with no shared eQTLs, power between CEU and YRI is 0.02, while power is higher for CEU to AA (0.82) and YRI to AA (0.86). TWAS power for expression predicted from AA to CEU (0.39) or YRI (0.38) is much lower due to the aforementioned structure of eQTL inheritance; when CEU and YRI share 0 of 10 eQTLs, AA has 20 eQTLs, 10 from each ancestral population. As the proportion of shared eQTLs jumps from 0% to 50% and 100%, power increases across all cross-population scenarios, reaching up to 0.86 (YRI to AA, 100% shared eQTLs). When eQTLs are fully shared, power from YRI to AA (0.86) is higher than from CEU to AA (0.83), indicating an effect of genetic distance on prediction quality. Indeed, when controlling for eQTL architecture, increasing genetic similarity between reference and target populations yields more significant median association test *t*-statistics ([S23 Fig](#pgen.1008927.s035){ref-type="supplementary-material"}).

![Curves depicting power to detect association under various TWAS scenarios.\
The x-axis represents the proportion of phenotypic variance explained by gene expression. As in [*Fig* 4](#pgen.1008927.g004){ref-type="fig"}, AA reflects simulated African-Americans constructed from YRI and CEU. The curves represent logistic interpolations of whether or not the causal gene was declared significant in an association test of a phenotype from the testing population with gene expression predicted from a training population into the testing population. Gray areas denote 95% confidence regions of mean power conditional on the effect size.](pgen.1008927.g005){#pgen.1008927.g005}

![Power for phenotype-expression association tests with cross-population imputed gene expression for heritability h^2^ = 0.205.\
The cross-population scenarios are ordered left to right from least admixture (CEU to YRI, 0% admixture proportion in our simulation) to most admixture (YRI to AA, 80% admixture proportion). Power increases on two axes: (1) as the proportion of shared eQTL architecture increases, and, to a lesser extent, (2) as genetic distance decreases between reference and target populations. Power is consistently high when training and testing populations match.](pgen.1008927.g006){#pgen.1008927.g006}

Admixture proportion interpolates power in two-way admixture {#sec007}
------------------------------------------------------------

The results in [Fig 6](#pgen.1008927.g006){ref-type="fig"} show how genetic distance affects power in TWAS association tests for one particular admixture proportion, but offer limited insight about how power changes across the admixture spectrum. To understand how admixture proportion affects TWAS power in a general admixed population with two ancestral populations, we simulated multiple admixed populations from CEU and YRI with admixture proportions varying at 10% increments. When the admixed population has 0% YRI admixture, it is fully drawn from haplotypes from CEU, whereas a population with 100% YRI admixture is drawn exclusively from haplotypes from YRI. It is important to note that in neither case does the admixed population exactly match the reference CEU or YRI since the genotypes for the admixed population are formed from an independent shuffling of the CEU or YRI haplotypes. For each admixed population, we estimated prediction models of gene expression as done in our previous analyses. For computational efficiency, we investigated the scenario of 50% shared eQTLs across reference populations and the number of eQTLs per gene equal to 10. Populations still shared the same causal gene, effect size, and environmental noise model.

[Fig 7](#pgen.1008927.g007){ref-type="fig"} shows power across admixture proportions for all cross-population scenarios. The phenotypes were simulated at effect sizes β = 0.005, 0.01, and 0.025, and environmental variance σ^2^ = 0.01, corresponding to heritability *h*^2^ = 0.06, 0.20, and 0.58, respectively. To compare and contrast across each train and test scenario, we plot the overall trends of performance in [Fig 7](#pgen.1008927.g007){ref-type="fig"}, and provide the exact mean power estimates and 95% confidence intervals for each scenario in [S10](#pgen.1008927.s010){ref-type="supplementary-material"}--[S12](#pgen.1008927.s012){ref-type="supplementary-material"} Tables. To avoid confusion with previous references to AA, which had a fixed admixture proportion, here we denote the admixed population for all proportions as AD. As expected, statistical power increases with the genetic heritability of the phenotype for all prediction scenarios. However, the different admixture proportions yield directional changes in power when gene expression is predicted to or from AD. For example, when h^2^ = 0.20 and gene expression is predicted from AD to CEU, power at 0% YRI admixture is 0.56 (95% CI: 0.462--0.658) and declines linearly with increasing YRI admixture; at 100% YRI, statistical power for AD to CEU is 0.46 (95% CI: 0.362--0.558). For AD to YRI, power at 0% YRI admixture starts at 0.42 (95% CI: 0.323--0.512) and increases linearly to 0.53 (95% CI: 0.431--0.628) at 100% YRI. We observe similar changes in power for CEU to AD (decreasing power as YRI proportion increases) and YRI to AD (increasing power as YRI proportion increases). The four directional trends also hold for *h*^2^ = 0.06 and *h*^2^ = 0.58, though power for cross-population scenarios involving AD is much lower in the former case and almost universally high in the latter case. In essence, the varying admixture proportions in this two-way admixed population yield a continuous linear trend of statistical power between the two ancestral populations: when AD is genetically closer to CEU, power for gene expression predicted in these populations is highest, and declines as AD becomes genetically closer to YRI. Similarly, when predicting from AD to YRI or vice versa, power is lowest when the two populations are genetically distinct, intermediate as the two populations become more genetically similar, and maximized when they are most alike.

![Power for various cross-population train-test scenarios with varying YRI admixture for three phenotypic heritability levels h^2^ = 0.06, 0.20, and 0.58, corresponding to effect sizes 0.005, 0.01, and 0.025, respectively.\
Power increases as heritability increases, but also as populations become more genetically similar. Raw power estimates and 95% confidence intervals are listed in [S10](#pgen.1008927.s010){ref-type="supplementary-material"}--[S12](#pgen.1008927.s012){ref-type="supplementary-material"} Tables.](pgen.1008927.g007){#pgen.1008927.g007}

Discussion {#sec008}
==========

Our goal with this study was to understand the extent to which gene expression prediction models estimated in one population can accurately predict the genetic component of gene expression in a different population. Cross-population generalizability of gene expression prediction models is an important but understudied issue for TWAS analyses. Among TWAS resources, we focused on PrediXcan as a test case with openly distributed prediction models available for multiple populations \[[@pgen.1008927.ref006],[@pgen.1008927.ref038]\]. Using 39 subjects from the SAGE study \[[@pgen.1008927.ref039]--[@pgen.1008927.ref042]\] we compared predicted expression values from PrediXcan models to measured gene expression on the same subjects and found that predictions matched poorly to measurements. Our investigation with the GEUVADIS dataset \[[@pgen.1008927.ref043]\] offered us a more homogenous environment and larger sample size in which to train and test gene expression prediction models. Prediction quality in GEUVADIS using both continental and constituent subpopulations provided stronger evidence of cross-population generalizability issues with transcriptome prediction, but could not control for eQTL predictors that vary between populations. To that end, our simulation of an admixed population from 1000 Genomes CEU and YRI haplotypes \[[@pgen.1008927.ref004],[@pgen.1008927.ref044]\] allowed us to finely control eQTL positions and effects as well as the causal genes in a TWAS. The simulation results show that both gene expression prediction accuracy and statistical power decrease as population eQTL models begin to diverge and genetic distance increases between populations for varying admixture proportions.

Our results highlight two points: firstly, since prediction within populations is better than prediction between populations, our results reaffirm prior investigations \[[@pgen.1008927.ref038]\] that population matching matters for optimally predicting gene expression. This is consistent with our results of impaired transcriptome prediction performance in SAGE with currently available resources. Secondly, despite decreased prediction accuracy when predicting between different populations, the populations that are more closely genetically related demonstrate somewhat better cross-population prediction and power to detect associations in TWAS. Our simulations of prediction between ancestral populations and an admixed one under varying admixture proportions neatly summarize this relationship: the admixture proportion from each ancestral population interpolates the power available from each ancestral population, and power is maximized when the admixed population is most closely related to one or the other ancestral population. However, while the differences in power under varying admixture are statistically meaningful, they are smaller than differences attributable to different eQTL architectures or to different levels of genetic heritability of a phenotype.

Prediction results from GTEx, DGN, and MESA into SAGE suggest that current predictive models, even for genes with greater heritability, perform worse than expected despite matching tissue types. Our investigation into cross-population prediction accuracy with GEUVADIS data replicates this lack of cross-population generalizability as observed with current predictive models from PredictDB, demonstrating that heterogeneity in RNA-Seq protocols does not fully explain our observations. Our results parallel prior evidence \[[@pgen.1008927.ref045]\] that PredictDB models themselves do not predict as well as expected into GEUVADIS despite controlling for tissue type, strongly suggesting that our observations about PrediXcan predictions in SAGE could hold true in other datasets. Since transcriptome prediction models use multivariate genotype predictors trained on a specific outcome, the impaired cross-population application can be viewed as an analogous observation to that seen previously in polygenic scores \[[@pgen.1008927.ref035]\].

Our simulations control for many technical issues that are otherwise difficult to overcome with real data, such as oracular knowledge of positions and effect sizes of causal eQTLs. Nevertheless, in our simulations we see issues with cross-population prediction that we first observed when applying existing PrediXcan models to SAGE genotype data. Certainly, SAGE differs in important ways from GTEx, DGN, and MESA: SAGE is a pediatric asthma case-control cohort study in African-American children, so we cannot rule out technical heterogeneity introduced by differences in age, study design, and ethnicity. Furthermore, our SAGE sample includes RNA-Seq data for *n* = 39 subjects, a dataset leveraged previously to validate genetic associations, but is nevertheless somewhat small by contemporary standards \[[@pgen.1008927.ref039]\]. However, technical heterogeneity between SAGE and existing PrediXcan models cannot solely explain the poor prediction performance. Our simulation results strongly suggest that problematic cross-population prediction performance between PrediXcan models and SAGE is deeper than differences in expression data.

Our investigations into the architecture of gene expression indicate that the power to detect associations is primarily determined by the degree of shared eQTLs across populations. In our simulations, this can be approximated as a (quasi-)linear interpolation of the prediction in the ancestral or reference populations into the admixed populations. However, the same is not true of overall levels of power in the admixed population: under 100% shared eQTL scenarios, cross-population generalizability is high, so the choice of training population matters less. In practical terms, this result bodes well for prediction of genes with eQTLs that do not vary by population. It is curious that in high-heritability genes, even models that share no eQTLs still retain power to detect scenarios: for genetically distant populations (CEU and YRI), power ranges from 0.10--0.14. Without shared eQTLs, this implies that local linkage disequilibrium between population-specific eQTLs, combined with high heritability, enables some degree of cross-population prediction. When cross-population statistical power is driven by LD and *h*^2^ instead of expression signals, then subsequent interpretation of association hits, such as direction and strength of effect, becomes difficult to link to actual biological relationships between phenotype and gene expression.

It is important to note that our observations do not reflect shortcomings of either the initial PrediXcan or TWAS frameworks. Nor do our findings affect the positive discoveries made using these frameworks over the past several years. These methods fully rely on the data used as input for training, and the most commonly used datasets for model training are overwhelmingly of European descent. Here we note that the current models fail to capture the complexity of the cross-population genomic architecture of gene expression for populations of non-European descent. Failing to account for this could lead researchers to draw incorrect conclusions from their genetic data, particularly as these models would lead to false negatives.

To this end, our simulations strongly suggest that predicting gene expression in a target population is improved by using predictive models constructed in a genetically similar training population. Maximizing prediction quality crucially depends on both genetic architecture and eQTL architecture. If populations share the exact same eQTL architecture, then they are essentially interchangeable for the purposes of gene expression prediction so long as eQTLs are genotyped and accurately estimated, which remains a technological and statistical challenge. As the proportion of shared eQTL architecture decreases between two populations, both cross-population prediction quality and TWAS power decrease as well. In both SAGE and GEUVADIS, we observe cross-population patterns consistent with an imperfect overlap of eQTLs across populations. Ensuring representative eQTL architecture for all populations in genotype-expression repositories will require a solid understanding of true cross-population and population-specific eQTLs. However, expanding the amount of global genetic architecture represented in genotype-expression repositories, which can be accomplished by sampling more populations, provides the most desirable course for improving gene expression prediction models. Additionally, this presents an opportunity for future research in methods that could improve cross-population generalizability, particularly when one population is over-represented in reference data. Tools from transfer learning could facilitate porting TWAS eQTL models from reference populations to target populations using little or no RNA-Seq data.

In light of the surging interest in gene expression prediction and TWAS, we see a pressing need for freely distributed predictive models of gene expression estimated from coupled transcriptome-genome data sampled in a variety of populations and tissues. The recently published predictive models with multi-ethnic MESA data constitute a crucial first step in this direction for researchers working with admixed populations \[[@pgen.1008927.ref038]\]. However, the clinical and biomedical research communities must push for more diverse genotype-expression resources to ensure that the fruits of genomic studies benefit all populations.

Online resources {#sec009}
----------------

PredictDB: <http://predictdb.org/>

GTEx: <http://gtexportal.org/>

DGN: <http://dags.stanford.edu/dgn/>

GEUVADIS: <https://www.ebi.ac.uk/Tools/geuvadis-das/>

Source code: <https://github.com/asthmacollaboratory/sage-geuvadis-predixcan>

Results and simulation data: <https://doi.org/10.7272/Q6RN362Z>

Methods {#sec010}
=======

Ethics statement {#sec011}
----------------

This study uses data from the Study of African Americans, Asthma, Genes, and Environments (SAGE) cohort, approved for human subjects research under expedited review by UCSF IRB 10--02877 with reference \#244919. All subjects gave written consent for genotyping, phenotyping, and data usage for general research use.

Genotype and RNA-Seq data {#sec012}
-------------------------

RNA-Seq (RNA sequencing) data generation and cleaning protocols for 39 SAGE subjects analyzed here were initially described in (Mak, White, Eckalbar, et al. 2018) \[[@pgen.1008927.ref039]\]. Genotypes were generated on the Affymetrix Axiom array as described previously \[[@pgen.1008927.ref058]\]. Genotypes were then imputed on the Michigan Imputation Server \[[@pgen.1008927.ref059]\] with EAGLE v2.3 \[[@pgen.1008927.ref060]\] and the 1000 Genomes panel phase 3 v5 \[[@pgen.1008927.ref044]\] and then subjected to the following filters: missing samples \< 5%, missing genotypes at any given SNP \<5%, SNP minor allele frequency \> 1%, p-value for deviation from Hardy-Weinberg Equilibrium \>1 x 10^−4^, and genotype imputation R^2^ \> 0.3. The choice of the 1000 Genomes panel follows GTEx protocol, though GTEx used the smaller 1000 Genomes phase 1 panel \[[@pgen.1008927.ref004]\]. Gene expression counts were processed through the GTEx v6p eQTL quality control pipeline and as described previously \[[@pgen.1008927.ref018]\]. Per GTEx protocol, gene expression values were corrected for 3 genotype principal components, 15 PEER factors, and sex. Gene expression values were filtered to have \>0.1 reads per kilobase per million reads (RPKM) in at least 10 individuals and at least 6 reads in at least 10 individuals. This filtering process kept 20,985 genes with Ensembl identifiers for analysis, of which 20,268 were autosomal genes. We then quantile normalized the remaining gene expression values across samples as our gene expression measurements.

GEUVADIS genotype VCF files and normalized gene expression data (filename GD462.GeneQuantRPKM.50FN.samplename.resk10.txt.gz) were downloaded directly from the EMBL-EBI GEUVADIS Data Browser. Genotypes were filtered similarly to SAGE subjects. No manipulation was performed on expression data. This process yielded 23,722 genes for analysis.

Running PrediXcan models {#sec013}
------------------------

We ran PrediXcan on SAGE subjects using PredictDB prediction weights from three paired genotype-expression datasets from PredictDB: GTEx, DGN, and MESA \[[@pgen.1008927.ref006],[@pgen.1008927.ref009],[@pgen.1008927.ref038],[@pgen.1008927.ref061]\]. For GTEx, we used both GTEx v6p and GTEx v7 weights. For MESA, we used all weight sets from the freeze dated 2018-05-30: African Americans (MESA_AFA), African Americans and Hispanics (MESA_AFHI), Caucasians (MESA_CAU), and all MESA samples (MESA_ALL). Overall, the analysis included 11,545 genes, of which only 273 had *both* normalized RNA-Seq measures and predictions from *all* weight sets. Of these, 126 had positive correlation between prediction and measurement. We assessed prediction quality by comparing PrediXcan predictions to normalized gene expression from SAGE using linear regression and correlation tests.

Estimation of prediction models {#sec014}
-------------------------------

We trained prediction models in GEUVADIS on genotypes in a 500Kb window around each of 23,723 genes with measured and normalized gene expression. GEUVADIS subjects were partitioned into various groups: the Europeans (EUR373), the non-Finnish Europeans (EUR278), the Yoruba (AFR), and the constituent 1000 Genomes populations (CEU, GBR, TSI, FIN, and YRI). For each training set, we performed nested cross-validation. The external cross-validation for all populations used leave-one-out cross-validation (LOOCV). The internal cross-validation used 10-fold cross-validation for EUR373 and EUR278 and LOOCV for the five constituent GEUVADIS populations in order to fully utilize the smaller sample size (*n* = 89) compared to EUR278 (*n* = 278) and EUR373 (*n* = 373). Internal cross-validation used elastic net regression with mixing parameter 𝛼 = 0.5 as implemented in the glmnet package in R. The nonzero weights for each SNP from each LOOCV were compiled and averaged for each gene, yielding a single set of prediction weights for each gene. Predictions were computed by parsing genotype dosages from the target population corresponding to the nonzero SNP predictors, and then multiplying dosages against the prediction weights. The resulting predictions were compared to normalized gene expression measurements downloaded from the GEUVADIS data portal. We applied two additional filters to ensure that gene expression models were suitable for analyses. Firstly, we removed genes that did not have any eQTLs in their predictive models. Secondly, genes where fewer than half of the individuals had nonmissing predictions were removed from further analysis. This latter filter discarded those genes for which expression was not easy to predict across multiple samples. Coefficients of determination (R^2^) were computed with the lm function in R. Spearman correlations were computed with the cor.test function in R.

Simulation of gene expression {#sec015}
-----------------------------

We downloaded a sample of 20,085 HapMap 3 SNPs \[[@pgen.1008927.ref055]\] from each of CEU and YRI on chromosome 22 as provided by HAPGEN2 \[[@pgen.1008927.ref056]\]. The data include 234 phased haplotypes for CEU and 230 phased haplotypes for YRI. We forward-simulated from these haplotypes to obtain two populations of *n* = 1000 individuals each. We then sampled haplotypes in proportions of 80% YRI and 20% CEU to obtain a mixture of CEU and YRI where the ancestry patterns roughly mimic those of African Americans. For computational simplicity, and in keeping with the high ancestry LD present in African Americans \[[@pgen.1008927.ref062],[@pgen.1008927.ref063]\], for each gene we assumed local ancestry was constant for each haplotype. For each of the three simulated populations, we applied the same train-test-validate scheme used for cross-population analysis in GEUVADIS. Genetic data for model simulation were downloaded from Ensembl 89 and included the largest 100 genes from chromosome 22. We defined each gene as the start and end positions corresponding to the canonical transcript, plus 1 megabase in each direction. We removed two genes, *PPP6R2* and *MOV10L1*, that spanned no polymorphic markers within 2 megabases of their start and end positions in the HapMap3 dataset, resulting in 98 gene models used for analysis. To simulate predictive eQTL models, we tested multiple parameter configurations for each gene: we varied the number of causal eQTLs in the ancestral populations (*k* = 1, 10, 20, and 40) and the proportion of shared eQTL positions (*p* = 0.0, 0.1, 0.2, ..., 0.9, 1) between ancestral populations. The admixed population always inherited all eQTLs from the ancestral populations. Causal eQTLs were chosen at random among SNPs with at least 5% minor allele frequency. The same 5% minor allele frequency floor was applied to each population. Each model included a simulated gene expression phenotype with *cis*-heritability set to 0.15. For each parameter configuration, we ran 100 different random instantiations of the model simulations.

Simulation of TWAS {#sec016}
------------------

Using the simulated gene expression measures with *k* = 10 causal eQTLs per gene in ancestral populations, we simulated a continuous phenotype with a known genetic architecture that depended on 1 causal gene. We tested prediction scenarios with 0%, 50%, and 100% eQTLs shared across populations. For each eQTL architecture, the three populations AA, CEU, and YRI shared the same causal gene *G*, the same causal effect size β, and the same environmental noise *ε*. *G* was chosen randomly. Effect sizes were fixed, and we tested various effect magnitudes β = 1 x 10^−5^, 5 x 10^−5^, 1 x 10^−4^, ..., 1 x 10^−1^, 5 x 10^−1^, 1, yielding a spectrum of phenotype heritability explained by gene expression. The environmental noise ε was drawn from an *N*(0,0.1^2^) distribution. Consequently, phenotypes therefore only varied with the expression measures from *G*. For a given population *c*, the phenotype *y*~*c*~ was then simulated as $$y_{c} = G\beta + \varepsilon.$$

For each combination of shared eQTL architecture, *G*, and β, this procedure yielded one *y*~*c*~ per individual in a population. We then performed a TWAS with *y*~*c*~ onto the *predicted* gene expression values, yielding three TWAS per *y*~*c*~, one for each reference prediction population. We then queried the resulting association *p*-value at G and tabulated whether it was declared significant (yes) or not (no) against a Bonferroni-corrected threshold of 0.05 / 98, accounting for all 98 genes in the TWAS. We ran this procedure for 100 random instantiations of (*G*, *ε*) and computed association test power with a logistic interpolation of the yes/no results.

Analysis tools {#sec017}
--------------

Analyses used GNU parallel \[[@pgen.1008927.ref064]\]. The R packages used for analysis include argparser, assertthat, data.table, doParallel, dunn.test, knitr, optparse, peer, the Bioconductor packages annotate, biomaRt, and preprocessCore, and the tidyverse bundle \[[@pgen.1008927.ref065]--[@pgen.1008927.ref076]\]. All plots were generated with ggplot2 \[[@pgen.1008927.ref077]\].

Supporting information {#sec018}
======================

###### Summary statistics for analyzing gene expression prediction in SAGE for all seven weight sets in PredictDB.

SAGE has measurements for 20,985 genes, of which 20,268 are autosomal. The intersection of genes with both predictions and measurements in SAGE across all seven weight sets is 273 (see [S4](#pgen.1008927.s016){ref-type="supplementary-material"}--[S6](#pgen.1008927.s018){ref-type="supplementary-material"} Figs), of which 39 produce predictions positively correlated to data in all comparisons (see [S7](#pgen.1008927.s019){ref-type="supplementary-material"} and [S8](#pgen.1008927.s020){ref-type="supplementary-material"} Figs).

(XLSX)

###### 

Click here for additional data file.

###### Summary statistics for each filtering step in the analysis of gene expression models from GEUVADIS for the 3 training populations EUR373, EUR278, and AFR.

The analysis of prediction vs. measurement contains 5038 genes in common between all three populations. Of these genes, 1476 genes demonstrate positive correlation between predictions and measurements.

(XLSX)

###### 

Click here for additional data file.

###### SNPs in linkage disequilibrium with rs28450894, on which SAGE RNA-Seq data were ascertained.

Each SNP is a prediction weight in at least one prediction weight set (Prediction Weights). SNPs corresponding to the largest two R^2^ values for each repository are listed here.

(XLSX)

###### 

Click here for additional data file.

###### R2 between predictions and observations for gene SLC39A8 (Ensembl ID ENSG00000138821).

Some predictors for *SLC39A8* are in linkage disequilibrium with SNP rs28450894, but the resulting R^2^ are not obviously biased away from 0.

(XLSX)

###### 

Click here for additional data file.

###### Summary statistics from training and testing results with continental GEUVADIS populations for gene models with positive correlations.

The R^2^ correspond to [Table 1](#pgen.1008927.t001){ref-type="table"}. The column "Correlation" lists the Spearman correlations for each scenario, while "Transcripts" gives the number of gene models used to compute the R^2^ and correlation summaries.

(XLSX)

###### 

Click here for additional data file.

###### Spearman correlations between prediction versus simulated measurement from simulated populations to themselves across various shared eQTL proportions for k = 10 causal eQTLs.

(XLSX)

###### 

Click here for additional data file.

###### Prediction performance under fully shared eQTL architecture for k = 10 eQTLs yields reliable cross-population gene expression prediction.

Results for other sizes of eQTL models are similar.

(XLSX)

###### 

Click here for additional data file.

###### A Dunn test shows statistically significant differences when predicting between AFR and EUR populations versus predicting between EUR populations.

(XLSX)

###### 

Click here for additional data file.

###### Differences in cross-population prediction performance are statistically significant, with a few notable exceptions.

Prediction from AA to CEU or YRI is essentially the same, but all other scenarios are different, indicating that the direction of prediction does matter.

(XLSX)

###### 

Click here for additional data file.

###### Power estimates and 95% confidence intervals for each train-test scenario (Train-Test) and each proportion of YRI (YRI proportion) corresponding to the left panel of [Fig 7](#pgen.1008927.g007){ref-type="fig"} for effect size 0.005 (h^2^ = 0.06).

(XLSX)

###### 

Click here for additional data file.

###### Power estimates and 95% confidence intervals for each train-test scenario (Train-Test) and each proportion of YRI (YRI proportion) corresponding to the center panel of [Fig 7](#pgen.1008927.g007){ref-type="fig"} for effect size 0.01 (h^2^ = 0.20).

(XLSX)

###### 

Click here for additional data file.

###### Power estimates and 95% confidence intervals for each train-test scenario (Train-Test) and each proportion of YRI (YRI proportion) corresponding to the right panel of [Fig 7](#pgen.1008927.g007){ref-type="fig"} for effect size 0.01 (h^2^ = 0.58).

(DOCX)

###### 

Click here for additional data file.

###### Distributions of log-transformed values of transcripts-per-million (TPM) from GTEx v7.

The overall distribution of gene expression values from GTEx v7 ("All GTEx v7 genes") shows lower average gene expression than the 273 genes in common across all PrediXcan sets ("Common genes") as well as the 39 of those genes with positive correlation. TPM values were downloaded directly from GTEx v7 ([gtexportal.org](http://gtexportal.org)).

(TIFF)

###### 

Click here for additional data file.

###### Distribution of R^2^ in SAGE.

In contrast to [Fig 1](#pgen.1008927.g001){ref-type="fig"}, the comparison to test R^2^ from PredictDB is removed to facilitate comparison of prediction weight sets in SAGE. The weight sets are ordered from left to right: GTEx v6p, GTEx v7, DGN, MESA African Americans, MESA African Americans and Hispanics, MESA Caucasians, and all MESA subjects.

(TIFF)

###### 

Click here for additional data file.

###### Violin plots of R^2^ between predictions and measurements in SAGE, with testing R^2^ from each PrediXcan repository included for benchmarking.

The prediction weights used here are, from left to right: GTEx v6p, GTEx v7, DGN, MESA African Americans, MESA African Americans and Hispanics, MESA Caucasians, and all MESA subjects. Test R^2^ from model training in GTEx 7 and MESA ("test_R2_avg" in PredictDB) appear on the right and provide a performance baseline. R^2^ for SAGE cluster heavily near zero, while testing R^2^ from each repository are more evenly distributed.

(TIFF)

###### 

Click here for additional data file.

###### R^2^ of measured gene expression versus predictions from PrediXcan.

The prediction weights used here are, from left to right: GTEx v6p, GTEx v7, DGN, MESA African Americans, MESA African Americans and Hispanics, MESA Caucasians, and all MESA subjects. Test R^2^ from model training in GTEx 7 and MESA ("test_R2_avg" in PredictDB) appear on the right and provide a performance baseline.

(TIFF)

###### 

Click here for additional data file.

###### A violin plot of the R^2^ as shown in [S4 Fig](#pgen.1008927.s016){ref-type="supplementary-material"}.

Compared to the distributions from [S3 Fig](#pgen.1008927.s015){ref-type="supplementary-material"}, the test R^2^ from PrediXcan repositories show that these 273 genes are somewhat better predicted on average compared to all 11,545 genes shown in [Fig 1](#pgen.1008927.g001){ref-type="fig"}. However, R^2^ in SAGE are still heavily biased towards 0, indicating no obvious change in prediction quality.

(TIFF)

###### 

Click here for additional data file.

###### R^2^ in SAGE for all PrediXcan prediction weight sets, similar to [S4 Fig](#pgen.1008927.s016){ref-type="supplementary-material"}, but without testing R^2^ from PredictDB.

The distributions are taken over the 273 genes in common to all weight sets.

(TIFF)

###### 

Click here for additional data file.

###### R^2^ between prediction and measurement in SAGE only using the 39 genes with positive correlation between prediction and measurement in all weight sets and benchmarks.

(TIFF)

###### 

Click here for additional data file.

###### R^2^ in SAGE for all PrediXcan prediction weight sets, similar to [S7 Fig](#pgen.1008927.s019){ref-type="supplementary-material"}, but without testing R^2^ from PredictDB.

The distributions are taken over the 39 genes with positive correlation in all weight sets.

(TIFF)

###### 

Click here for additional data file.

###### A comparison of R^2^ from SAGE and MESA_ALL training diagnostics, similar to [Fig 3](#pgen.1008927.g003){ref-type="fig"}.

The SAGE R^2^ are computed from regressing PrediXcan predictions onto gene expression measurements. The MESA_ALL R^2^ are taken from PredictDB ("test_R2_avg").

(TIFF)

###### 

Click here for additional data file.

###### A comparison of R^2^ from SAGE and MESA_AFA training diagnostics, similar to [Fig 3](#pgen.1008927.g003){ref-type="fig"}.

The SAGE R^2^ are computed from regressing PrediXcan predictions onto gene expression measurements. The MESA_AFA R^2^ are taken from PredictDB ("test_R2_avg").

(TIFF)

###### 

Click here for additional data file.

###### A comparison of R^2^ from SAGE and MESA_AFHI training diagnostics, similar to [Fig 3](#pgen.1008927.g003){ref-type="fig"}.

The SAGE R^2^ are computed from regressing PrediXcan predictions onto gene expression measurements. The MESA_AFHI R^2^ are taken from PredictDB ("test_R2_avg").

(TIFF)

###### 

Click here for additional data file.

###### A comparison of R^2^ from SAGE and MESA_CAU training diagnostics, similar to [Fig 3](#pgen.1008927.g003){ref-type="fig"}.

The SAGE R^2^ are computed from regressing PrediXcan predictions onto gene expression measurements. The MESA_CAU R^2^ are taken from PredictDB ("test_R2_avg").

(TIFF)

###### 

Click here for additional data file.

###### Violin plots of the distribution of R^2^ from [Table 1](#pgen.1008927.t001){ref-type="table"}.

The train-test scenarios from left to right are Africans to Africans, Africans to non-Finnish Europeans, Africans to all Europeans, Africans to Finns, non-Finnish Europeans to Africans, non-Finnish Europeans to non-Finnish Europeans, non-Finnish Europeans to Finns, all Europeans to Africans, and all Europeans to all Europeans.

(TIFF)

###### 

Click here for additional data file.

###### Violin plots of the distribution of R^2^ from [Table 2](#pgen.1008927.t002){ref-type="table"}.

The groups are ordered as in [S13 Fig](#pgen.1008927.s025){ref-type="supplementary-material"}. The 564 genes presented here are somewhat better predicted than average. Effects of training sample size are evident, in which Europeans (EUR373, n = 373) generally yield higher R^2^ than Africans (AFR, n = 89). A notable distributional different exists between Europeans predicting into Africans (EUR373 to AFR) vs. Europeans (EUR373 to EUR373), the latter of which shows an upward bias of R^2^.

(TIFF)

###### 

Click here for additional data file.

###### Distributions of R^2^ across all 25 train-test scenarios using the 5 constituent GEUVADIS populations (CEU, FIN, GBR, TSI, and YRI).

The distributions correspond to [Table 3](#pgen.1008927.t003){ref-type="table"}. Distributions from scenarios where a population predicts into itself (CEU_CEU, FIN_FIN, GBR_GBR, TSI_TSI, or YRI_YRI) have noticeably fewer R^2^ near 0, indicating improved prediction.

(TIFF)

###### 

Click here for additional data file.

###### Distributions of R^2^ across 142 genes in common to all 25 train-test scenarios.

The train-test scenarios are ordered as in [S15 Fig](#pgen.1008927.s027){ref-type="supplementary-material"}. The 142 genes represented here are predicted better than average. Population-level differences can be seen, particularly between the four European populations (CEU, FIN, GBR, and TSI) and YRI.

(TIFF)

###### 

Click here for additional data file.

###### Prediction R^2^ between AFR (YRI) and EUR (CEU, TSI, GBR, and FIN).

Predicting into and from AFR produces consistently lower R^2^ than predicting within EUR, suggesting a potential decrease in prediction accuracy when predicting across continental population groups.

(TIFF)

###### 

Click here for additional data file.

###### Genetic distance versus prediction accuracy over 142 genes with positive correlation across all train-test scenarios.

Here the GEUVADIS populations are arranged into three groups. AFR to AFR includes prediction from YRI into itself; EUR to AFR includes prediction into YRI from CEU, GBR, TSI, and FIN; and EUR to EUR includes prediction within and between all European populations in GEUVADIS. Clustering by genetic distance separates prediction between European populations from prediction between European populations and AFR. F~ST~ are taken from the 1000 Genomes Project ([S11 Table](#pgen.1008927.s011){ref-type="supplementary-material"}) (The 1000 Genomes Consortium, 2010).

(TIFF)

###### 

Click here for additional data file.

###### A schematic of three shared eQTL architectures for the case of k = 10 eQTLs per gene.

Blue encodes eQTLs specific to CEU; red encodes eQTLs specific to YRI; and gold encodes eQTLs shared between CEU and YRI. Models for CEU and YRI always had k eQTLs. AA always inherited all eQTLs from the ancestral populations. Consequently, the number of eQTLs in AA varied depending on how many eQTLs CEU and YRI shared.

(TIFF)

###### 

Click here for additional data file.

###### Correlations between predictions and simulated gene expression measurements from simulated populations across various proportions of shared eQTL architecture with 20 causal cis-eQTLs.

(TIFF)

###### 

Click here for additional data file.

###### Correlations between predictions and simulated gene expression measurements from simulated populations across various proportions of shared eQTL architecture with 40 causal cis-eQTLs.

(TIFF)

###### 

Click here for additional data file.

###### Mean correlations between predictions and simulated gene expression measurements from simulated populations for a single causal cis-eQTL.

For this simplified eQTL architecture, the ancestral populations (CEU and YRI) either share the causal eQTL (TRUE) or not (FALSE). In the TRUE case, AA has 1 eQTL shared with CEU and YRI; in the FALSE case, it has 2 unique eQTLs, one from each of CEU and YRI. Error bars denote 95% confidence intervals.

(TIFF)

###### 

Click here for additional data file.

###### Distributions of t-statistics across various shared eQTL proportions for all nine train-test scenarios with 1000 Genomes populations for a fixed TWAS effect size and fixed number of causal eQTLs.

The labels are ordered from left to right from least admixture proportion (CEU to YRI, 0% admixture proportion) to highest admixture proportion (YRI to AA, 80% admixture proportion), with train-test scenarios from a population into itself on the right of each panel. Increasing proportions of shared eQTLs yield stronger association statistics from cross-population predictions. Fully shared eQTL architectures yield consistently high power across populations. Median t-statistics increase as populations share more haplotypes, while association tests with gene expression predicted in the same population show consistently high power.

(TIFF)

###### 

Click here for additional data file.
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Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: Keys et al. use gene expression prediction models publicly available in PredictDB from multiple cohorts (DGN, GTEx, MESA) to predict gene expression in SAGE (n=39), an African American pediatric asthma cohort with genome-wide genotypes and whole blood RNA-Seq available. They assess predictive performance by comparing predicted expression to observed. They go on to build prediction models in GEUVADIS and test them within and between EUR and AFR populations within GEUVADIS. They also generate simulated African American data and show predictive performance and TWAS power increases with increased shared eQTL genetic architecture.

I have reviewed this paper previously at another journal and while the authors have added TWAS simulations and addressed most of my concerns, a major one remains. Since prediction performance in SAGE is poor across all PredictDB models tested, even among the best-predicted genes (Fig 3), is it the best cohort to use to address the question of cross-population generalizability, especially when larger datasets (GEUVADIS) are available? The authors should address whether a test set of 39 individuals is a suitable sample size for reliable estimates of performance. In addition to sample size, other confounders like age, population structure, and hidden confounders could also affect performance in SAGE. In the methods, you state that you followed the GTEx v6p eQTL QC pipeline, but details about how many PEER factors, genotypic PCs, etc. were used in your SAGE analyses are needed, especially given n=39 is much smaller than any GTEx eQTL tissue. By using just one small validation cohort in the first section of your paper (SAGE), key population performance differences among PredictDB models may be missed. I suggest using GEUVADIS populations as validation cohorts of PredictDB models to see if larger sample sizes reveal the expected differences among populations.

The GEUVADIS results as presented are stronger and a useful demonstration of the cross-population prediction problem observed by others (Mogil et al. 2018, Mikhaylova et al. 2019). The GEUVADIS prediction models built by the authors would be useful to the community and should be made publicly available. While summary stats (R2, rho) were available at <https://ucsf.box.com/v/sage-geuvadis-predixcan>, the prediction models (i.e. SNP weights per gene) were not included.

The simulations are thorough and well-presented, and the portion of this paper that goes beyond previous studies. Simulated population models with non-identical eQTLs showed patterns similar to real-world data. The authors call for more diverse sampling in transcriptome studies is timely and necessary in order better compare eQTL architecture among populations.

Minor:

1\. Line 322. Change "different" to "differences".

2\. Line 404. Add "in" to "predicted these populations".

3\. I think the last sentence fragment in Figure 5 legend should be deleted.

4\. Suppl. Fig. 5. Wide bar in the AA 50% circle should be yellow (shared), not red.

Reviewer \#2: Cross population prediction of gene expression is an incredibly timely subject given that the bulk of match genotype-gene expression data has been done in European ancestry individuals and is use to predict gene expression in diverse population, without complete understanding of the disadvantages or potential errors that may occur. This paper highlights the need to create prediction models in populations that reflect the ancestry of genotypes used to impute. The authors have used both real and simulated data to make this case, and overall, I feel that paper is useful to the human genetic community. But the manuscript suffers from errors in data visualization that distract from the message and leave the reader confused as to which is the true representation of the data. Below are outline comments to improve and correct these errors.

Major Comments.

1\. The number of gene models available in each weighted set would be highly dependent on the criteria used to identify these gene as "well predicted". As an example, depending on the R2 threshold the MESA_All set could have anywhere from 6896 gene model to 1336 gene models (as per the paper). The authors need to add details to the methods on what criteria was used to get to the final list of gene model that are compared. Where these thresholds the same for all weighed sets?

2\. By using all 11,545 genes in the analysis, it seems like it would bias the estimate downward. Especially since the authors compare these vales to the R2 from the training set which do not include all 11,545 genes in all models. While this point is somewhat answered by the GTExv7 analysis on well predicated genes, this does not address if this is true for the more diverse cohorts like MESA.

3\. The box and whiskers plot are not particularly informative to show the difference in R2 between the weighted sets as highlighted in the results. While I understand the want to graph the test R2 with the actual R2, I think it may be easier to see when graphed separately.

4\. As a follow up to comment 2, could the negative correlation described in results (lines 189 -- 195) be due to the inclusion of all 11K genes as oppose to those well predicted by each model. Would this still be the case if the authors restricted to just those genes listed in Supplementary Table 1?

5\. The results for the 564 genes that were trained in all GEUVADIS data should be presented similarly to the larger gene set (lines 241-247). Specifically, the author should highlight how the models trained on EUR fared in AFR and vise-versa as oppose to just giving ranges of the R2 across all comparisons.

6\. I would be helpful to know the population sizes for each on the subpopulations presented on table 3 and 4, unless all of these are 89 as stated in line 252

7\. I am a bit confused on the simulation in which the admixed population inherits causal eQTLs from the parental populations. The explanation in the results states that when k=10 and if only 50% of the alleles are shared, then the AA would have 15 causal eQTLs (5 from CEU, 5 from YRI and 5 shared). So, wouldn't that be 15 causal eQTLs not 10? Also, would it not make more sense use all 5 shared and for the remaining 5 use 80% of the YRI specific and 20% of the CEU specific? While the authors explain the effect of this in the result it is hard to interpret how the simulation would reflect actual admixture.

8\. I am confused by Figure 6 as the text and the figure do not seem to match. The authors states," For an architecture with no shared eQTLs, power between CEU to YRI is 0, while power is higher for CEU to AA (0.25) and YRI to AA (0.30)." But the bar chart shows CEU to AA and YRI to AA both to be close to identical at around 0.8.

9\. The matching of numbers reported in results to the figures continues on Figure 7 -- though admittedly closer. The authors wrote, "For example, when h2 = 0.20 and gene expression is predicted from AD to CEU, power at 0% YRI admixture is 0.56 (95% CI: 0.462 -- 0.658) and declines linearly with increasing YRI admixture; at 100% YRI, statistical power for AD to CEU is 0.46 (95% CI: 0.362 - 0.558)." but the line depicted is clearly at 0.5 when the YRI admixture is at 100%. The author need to thoroughly examine all figure to ensure they are depicting what is written in the text.

Minor comments:

1\. In the simulated gene expression, the author chose cis-heritability of 0.15. Is this the average across all tissues in GTEx, or only LCL, as this may be tissue specific?

2\. Why did the authors simulate the AA haplotypes as oppose to use the Hapmap ASW data and simulate haplotypes for that data?

3\. 2 gene were removed from the TWAS analysis because they had no SNPs in the simulated data. I think this mean there were no SNPs within 2Mb of these genes. This strikes the reviewer as very odd. What is the explanation for this?

4\. It would be useful to the reader to add the github repositories that contain the PredictDB models that were used in the paper.

5\. Gene numbers do not agree between the results and the methods. As an example, the methods states that 10,161 gene were found in at least one weighed set. But in the result the number is 11,545.

6\. The authors point out the least negative correlation was seen with MESA_AFHI and the most with MESA_AFA, but the number is the results are not shown on Supplementary Table 1.

7\. "Utahans" is misspelled on line 217

8\. Figure 5 is incomplete. The ledged reads, "A dotted red line at h2 = 0.95 marks the power values shown in". Shouldn't this be at 0.205 (assuming this is related to Figure 6) also there is no red line.

Reviewer \#3: In this manuscript, the authors describe a impressive set of analyses on the portability of gene expression QTLs (eQTLs) across diverse ancestries. They then extend this work to look at Transcriptome-Wide Association Studies (TWAS), and evaluate the extent of portability of these models across ancestry groups.

In the case of complex traits, we have larger sample sizes and are often discouraged by the losses in portability there, but this paper clearly makes the important point that the situation is even more discouraging for gene expression. The paper is well written and all analyses seem thoughtfull laid out. In addition, there has been momentous effort to make the data and software freely available, which should be commended. That being said, there are a few limitations to the current analyses, detailed below.

Major concerns:

1\) The data come from myriad studies of: whole blood, PBMCs, monocytes, and LCLs. There is not a direct comparison between sample types, despite the availability of GTEx models trained on both LCLs and whole blood. Adding such a comparison of trained LCL/WB models would help researchers apply the results. (The lack of direct comparison to monocytes is understandable given the very preliminary nature of the MESA whole blood RNA-seq data generated as part of TOPMed, and the lack of existing TWAS models. As such, lack of monocyte comparison I don\'t think is a concern.)

2\) GTEx, particularly in v8, has a substantial number of African-American and Hispanic participants with LCLs and Whole Blood. If possible, these should be included as a separate group for evaluation, to test whether the claim regarding SAGE and MESA_AFA is generalizable to other datasets. There are numerous different factors which might be contributing to the lack of reproducibility (e.g. WGS vs genotyping arrays; age effects; RNA isolation and sequencing protocols; source material; etc) and including GTEx Whole Blood and LCL expression in HIS and AFA individuals as evaluation sets would enable direct evaluation of some of these factors.

Points of minor analysis:

3\) It would be nice to know whether the 564 genes (Table 2), 142 genes (Table 4), or 273 genes (Supplementary Table 1) are representative of the whole transcriptome. A simple violin plot of the expression distribution of these genes and other genes, within each population, would suffice. It might be helpful to see their Test R\^2 estimates as well, but I don\'t think that\'s critical.

4\) Regarding the TWAS simulation: While the simulation itself only used 100 genes, I think that readers would also be interested in understanding the power were a whole genome expression panel were used. Is it possible to recompute significant thresholds and provide these \"transcriptome-wide\" significance estimates as well? It would also be useful to know what the expected variance explained by the genes is \-- my understanding, for beta = 1, is that you are adding N(0, 0.1\^2) noise still, so heritability should be very high? (It\'s a bit unclear whether the h\^2 = 0.15 applies to the TWAS simulation as well, and lines 143-149 of simulate_twas_sge.R seem to indicate that h\^2 isn\'t used.)

Points of clarification or minor analysis:

5\) Given that the SAGE participants were ascertained on the basis of rs28450894, some validation that effect sizes are not out of line at this locus is important to understanding the results. How close are the 273 genes to this SNP, and does this SNP (or a close LD partner) have non-zero weight in any models? It does seem rather unlikely that this SNP (or bronchodilator status in general) are driving the lack of signal, though, so simply acknowledging this and noting these distances and weights is sufficient in my opinion.

6\) It appears that there is now a HIS weight set for MESA available on [predictdb.org](http://predictdb.org) \-- I would suggest either including, or rewording \"all four\" (line 153) to \"four of the\".

7\) Are you powered (or is it possible to obtain) to estimate the heritability of the 273 genes in each population? Evaluating whether there is a relationship between R\^2 and h\^2 would be valuable. Currently, the Test R\^2 is the comparison group, which should still be included but is perhaps underpowered and should not be considered a true upper bound. In particular, it would be nice to know if h\^2 is different in AFA than in EUR. At the very least, showing a scatterplot of Test R\^2 in EUR vs AFA in MESA/GEUVADIS of the different gene sets would be helpful.

8\) Adding to Table 1 the number of individuals in the train and test populations, as well as the number of genes with positive correlation, would help with direct interpretation of Table 1 and Table 2. In addition to the R\^2 measures, perhaps a direct test of e.g. test statistic inflation be more interpretable?

Points of confusion or surprise in the text:

7\) What does it mean for CEU and YRI to have 0.0 shared ancestry? I see the simulation used haplotypes from CEU, YRI, or a mix thereof, but these sets of haplotypes can overlap. Some measure of haplotype sharing would be appreciated (or just stating the simulation proportion mixing directly, without making a population-level claim).

8\) Do you have a sense of why AA-\>AA is so much better than CEU-\>CEU or YRI-\>YRI in Supplemental Figure 9? Should I be interpreting this in the context of total haplotypic diversity in AA?

9\) It seems from Supp Table 3 like the FIN testing population, trained in AFR, does substantially better than the other EUR test populations. Any idea why that might be?

10\) For simulated gene expression that went into the TWAS, was there a minor allele frequency cutoff in choosing causal eQTLs? And was this matched across populations?

11\) \"The comparison of predictive models cannot easily differentiate predictions of 0 (no gene expression) and NA (missing expression) \[L570-572\].\" \-- Could you please clarify this statement?

Overall, this paper suggests (consistent with numerous other papers in the field) that prediction of binary and quantitative traits is not very portable across populations. This work extends that knowledge to gene expression, and importantly shows (through both real data and simulation) that the prediction accuracies are hindered as much or more than with complex traits.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: No: The GEUVADIS prediction models built by the authors would be useful to the community and should be made publicly available. While summary stats (R2, rho) were available at <https://ucsf.box.com/v/sage-geuvadis-predixcan>, the prediction models (i.e. SNP weights per gene) were not included.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No
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\* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. \*

Dear Dr Keys,

Thank you very much for submitting your Research Article entitled \'On the cross-population generalizability of gene expression prediction models\' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some minor aspects of the manuscript that should be improved. Please also respond to the reviewer\'s question about RNA-seq data access. 

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1\) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2\) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our [archive](http://www.plosgenetics.org/article/browse/volume). If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to <plosgenetics@plos.org>.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Tuuli Lappalainen

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: The authors have addressed my concerns satisfactorily. The only minor adjustment in the text I suggest is removing/rewording this sentence from the Introduction, line 138: "To our knowledge, nobody has investigated cross-population generalizability of new prediction models generated within GEUVADIS." Fryett et al. very recently (March 2020) published a study in Genetic Epidemiology that did this (<https://doi.org/10.1002/gepi.22290>). I understand their work was completed in parallel to yours, but I suggest removing this now inaccurate sentence. Doing so will in no way diminish your thorough investigation into the important problem of cross-population portability presented here. Thank you for your thoughtful response to the reviews and be well.

Reviewer \#3: Thank you for your thoughtful and thorough response piece. I appreciate your inclusion of this additional material and I believe the resulting work is acceptable. A few brief comments:

1\) It is worth noting that GTEx does have (self-report/close-relative-report) ethnicity in the ETHNCTY variable: <https://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs000424/phs000424.v8.p2/pheno_variable_summaries/phs000424.v8.pht002742.v8.p2.GTEx_Subject_Phenotypes.var_report.xml> which I note because it might be helpful to include in future analyses. However, while I would still like to see the relative differences due to switching datasets versus switching cell types, I think the data are fine as they are. I would just request the authors make this limitation more clear, and that the predictions observed might change on other datasets from the same cell type versus on different cell types within whole blood.

2\) In particular, I don\'t understand the argument that GTEx v8 and GTEx v7 are sufficiently different that they cannot be compared. Were that the case, would SAGE not also be too different to be compared? It might be worth noting cases under which whole blood could be predicted more accurately than in LCLs, e.g. <https://pubmed.ncbi.nlm.nih.gov/19043577/>.

3\) In the abstract: \"the amount of shared genotype predictors\" is unclear and I would re-word to indicate that this refers to genetic variants included in the model.

4\) The following response: \"However, in light of the issues seen during our test, we believe that displaying the correlations is a more appropriate description and that there would be limited test statistic inflation.\" Suggests to me that including the test statistic inflation analysis would aid interpretation of the results. Alternatively, the fraction of FDR-adjusted positive correlations (under a half-normal distribution) could play a similar role. I think that everyone expects the power to be limited, but it is useful to have some measure of error on the R\^2 measures. (for instance, with the current rendition it is unclear whether FIN is indeed better predicted than EUR278 with AFR weights)

5\) Regarding your response to the FIN prediction, it suggests that if heterogeneity is driving differences in prediction, a meta-analysis across populations might be more appropriate. However I think the point is clear enough as is that such an analysis is likely above and beyond.

Otherwise, I think the manuscript is clear and comprehensive.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: No: SAGE RNA-Seq data did not appear to be available through dbGaP phs000921.v4.p1, just WGS. Please correct me if I\'m wrong or provide an RNA-Seq accession or details on how the RNA data may be accessed.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#3: No
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10 Jun 2020

Dear Dr Keys,

We are pleased to inform you that your manuscript entitled \"On the cross-population generalizability of gene expression prediction models\" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plosgenetics@plos.org>.

In the meantime, please log into Editorial Manager at <https://www.editorialmanager.com/pgenetics/>, click the \"Update My Information\" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Tuuli Lappalainen

Associate Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

[www.plosgenetics.org](http://www.plosgenetics.org)

Twitter: \@PLOSGenetics

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Comments from the reviewers (if applicable):

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Data Deposition**

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the [Dryad Digital Repository](http://www.datadryad.org). As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our [website](http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories).

The following link will take you to the Dryad record for your article, so you won\'t have to re‐enter its bibliographic information, and can upload your files directly: 

<http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-19-01922R2>

More information about depositing data in Dryad is available at <http://www.datadryad.org/depositing>. If you experience any difficulties in submitting your data, please contact <help@datadryad.org> for support.

Additionally, please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Press Queries**

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper\'s publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there\'s anything the journal should know or you\'d like more information, please get in touch via <plosgenetics@plos.org>.

10.1371/journal.pgen.1008927.r006
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PGENETICS-D-19-01922R2

On the cross-population generalizability of gene expression prediction models

Dear Dr Keys,

We are pleased to inform you that your manuscript entitled \"On the cross-population generalizability of gene expression prediction models\" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Matt Lyles

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN \| United Kingdom

<plosgenetics@plos.org> \| +44 (0) 1223-442823

[plosgenetics.org](http://plosgenetics.org) \| Twitter: \@PLOSGenetics

[^1]: We have read the journal\'s policy and one author of this manuscript (Chris Gignoux) has the following competing interests: ownership of stock in 23andMe. The remaining authors have declared that no competing interests exist.

[^2]: ‡ These authors are joint senior authors on this work.
